Omega Fund VI, L.P.

Lexeo Therapeutics, Inc. · 10% Owner

Omega Fund VI, L.P. serves as a 10% owner of Lexeo Therapeutics, Inc. and has been active in recent SEC Form 4 filings. On November 9, 2023, the firm reported a substantial purchase of approximately $5.0 million in Lexeo Therapeutics (LXEO), marking a significant move in their investment strategy. This profile details their trading activity, highlighting their focus on the manufacturing sector and the implications of their recent investment decisions.

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.